Cargando…

Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network

SIMPLE SUMMARY: Gynecologic carcinosarcomas are rare and aggressive diseases with a poor prognosis. The rarity of these tumors explains the lack of robust and specific data available in the literature. Using the data from the French National Rare Malignant Gynecological Tumors (TMRG) network, we con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romeo, Clémence, Le Saux, Olivia, Jacobs, Margaux, Joly, Florence, Ferron, Gwenael, Favier, Laure, Fumet, Jean-David, Isambert, Nicolas, Colombo, Pierre-Emmanuel, Sabatier, Renaud, Bastide, Ludovic, Charreton, Amandine, Devouassoux-Shisheboran, Mojgan, Gertych, Witold, Dubot, Coraline, Bello Roufai, Diana, Bataillon, Guillaume, Berton, Dominique, Kalbacher, Elsa, Pautier, Patricia, Pomel, Christophe, Cornou, Caroline, Treilleux, Isabelle, Lardy-Cleaud, Audrey, Ray-Coquard, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773830/ https://www.ncbi.nlm.nih.gov/pubmed/35053517 http://dx.doi.org/10.3390/cancers14020354

Ejemplares similares

Single Event Effects mitigation with TMRG tool
por: Kulis, S
Publicado: (2017)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network
por: Nigon, Elsa, et al.
Publicado: (2023)

Polypoid endometriosis of the Douglas pouch
por: Jacquot, A, et al.
Publicado: (2020)

Recent advances in understanding and managing leiomyosarcomas
por: Duffaud, Florence, et al.
Publicado: (2015)

Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer
por: Drouet, Youenn, et al.
Publicado: (2018)

Pathobiology of ovarian carcinomas
por: Devouassoux-Shisheboran, Mojgan, et al.
Publicado: (2015)

CREB fusion–associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype
por: Trecourt, Alexis, et al.
Publicado: (2023)

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)
por: Martel-Lafay, Isabelle, et al.
Publicado: (2021)

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2022)

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
por: Gouy, Sebastien, et al.
Publicado: (2017)

Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types
por: Gouy, Sebastien, et al.
Publicado: (2017)

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
por: Ray-Coquard, Isabelle, et al.
Publicado: (2020)

Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
por: Bonnet, Elise, et al.
Publicado: (2022)

“Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors”
por: Gernier, François, et al.
Publicado: (2021)

EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice
por: Morel, Anne-Pierre, et al.
Publicado: (2012)

New developments in treatment of ovarian carcinoma: focus on trabectedin
por: Cassier, Philippe A, et al.
Publicado: (2010)

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
por: Labidi-Galy, Sana Intidhar, et al.
Publicado: (2012)

The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review
por: Lauby, Ambroise, et al.
Publicado: (2021)

Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial
por: Fumet, Jean-David, et al.
Publicado: (2022)

Can AI predict epithelial lesion categories via automated analysis of cervical biopsies: The TissueNet challenge?
por: Loménie, Nicolas, et al.
Publicado: (2022)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

Diagnostic yield and therapeutic impact of open lung biopsy in the critically ill patient
por: Philipponnet, Carole, et al.
Publicado: (2018)

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group
por: Heudel, P-E, et al.
Publicado: (2017)

Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study
por: Alejandra, Martinez, et al.
Publicado: (2021)

Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer
por: Fumet, Jean-David, et al.
Publicado: (2018)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History
por: Brahmi, Mehdi, et al.
Publicado: (2020)

Molecular Characterization of Ovarian Yolk Sac Tumor (OYST)
por: Hodroj, Khalil, et al.
Publicado: (2021)

Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database
por: Bini, Marta, et al.
Publicado: (2022)

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer
por: Cassier, Philippe A, et al.
Publicado: (2011)

The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells()
por: Jacqueroud, Laurent, et al.
Publicado: (2016)

Individual variation and repeatability of methane production from dairy cows estimated by the CO(2) method in automatic milking system
por: Haque, M. N., et al.
Publicado: (2015)

Molecular Mechanisms of Kaposi Sarcoma Development
por: Karabajakian, Andy, et al.
Publicado: (2022)

Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France
por: Huguet, Marius, et al.
Publicado: (2018)

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer
por: Nguyen Van Long, Flora, et al.
Publicado: (2022)

Predictive factors for severe placental damage in pregnant women with SARS-CoV-2 infection
por: Damman, Elise, et al.
Publicado: (2023)

What underlies the observed hospital volume-outcome relationship?
por: Huguet, Marius, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8udqhs2svanv75at6q7gb4shj3